LGT Capital Partners LTD. Purchases 442,500 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

LGT Capital Partners LTD. boosted its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 79.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,000,000 shares of the company’s stock after buying an additional 442,500 shares during the quarter. LGT Capital Partners LTD. owned approximately 0.73% of AdaptHealth worth $7,290,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of AHCO. Commonwealth Equity Services LLC lifted its position in AdaptHealth by 1.8% during the third quarter. Commonwealth Equity Services LLC now owns 28,364 shares of the company’s stock valued at $532,000 after acquiring an additional 491 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in AdaptHealth by 2.9% during the second quarter. The Manufacturers Life Insurance Company now owns 30,979 shares of the company’s stock valued at $377,000 after buying an additional 887 shares during the period. First Republic Investment Management Inc. grew its position in shares of AdaptHealth by 3.8% during the 2nd quarter. First Republic Investment Management Inc. now owns 24,990 shares of the company’s stock valued at $451,000 after acquiring an additional 924 shares during the period. ProShare Advisors LLC grew its holdings in AdaptHealth by 9.2% in the second quarter. ProShare Advisors LLC now owns 11,574 shares of the company’s stock valued at $141,000 after purchasing an additional 978 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its stake in AdaptHealth by 2.7% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 37,652 shares of the company’s stock valued at $469,000 after acquiring an additional 984 shares during the period. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Stock Performance

Shares of AHCO opened at $11.51 on Friday. The company has a debt-to-equity ratio of 1.44, a current ratio of 1.21 and a quick ratio of 1.00. The business’s fifty day moving average price is $8.84 and its 200 day moving average price is $8.28. AdaptHealth Corp. has a 12-month low of $6.37 and a 12-month high of $15.37. The stock has a market capitalization of $1.53 billion, a PE ratio of -2.17, a price-to-earnings-growth ratio of 0.74 and a beta of 1.01.

AdaptHealth (NASDAQ:AHCO) last released its earnings results on Tuesday, February 27th. The company reported $0.64 earnings per share for the quarter, topping analysts’ consensus estimates of $0.20 by $0.44. The firm had revenue of $858.23 million during the quarter, compared to the consensus estimate of $825.94 million. AdaptHealth had a positive return on equity of 8.84% and a negative net margin of 21.21%. Equities research analysts forecast that AdaptHealth Corp. will post 0.88 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Royal Bank of Canada reissued an “outperform” rating and issued a $13.00 price target on shares of AdaptHealth in a research note on Monday, March 4th. UBS Group increased their price objective on AdaptHealth from $9.00 to $13.00 and gave the company a “buy” rating in a report on Wednesday, February 28th. Jefferies Financial Group cut shares of AdaptHealth from a “buy” rating to a “hold” rating and cut their target price for the company from $14.50 to $8.00 in a report on Monday, January 8th. Finally, Truist Financial upped their price target on AdaptHealth from $11.00 to $13.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $12.10.

Insider Buying and Selling

In other news, major shareholder James E. Flynn sold 52,487 shares of the company’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $10.93, for a total transaction of $573,682.91. Following the completion of the sale, the insider now owns 11,826,376 shares in the company, valued at approximately $129,262,289.68. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other AdaptHealth news, major shareholder James E. Flynn sold 182,607 shares of AdaptHealth stock in a transaction on Monday, March 11th. The stock was sold at an average price of $11.02, for a total value of $2,012,329.14. Following the completion of the transaction, the insider now owns 11,643,769 shares in the company, valued at approximately $128,314,334.38. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, major shareholder James E. Flynn sold 52,487 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $10.93, for a total transaction of $573,682.91. Following the completion of the transaction, the insider now directly owns 11,826,376 shares of the company’s stock, valued at $129,262,289.68. The disclosure for this sale can be found here. 13.60% of the stock is owned by corporate insiders.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.